E. H. Lin
Impact in
- Gastroenterology top 2%
- Gastrointestinal Tumor Research and Treatment
- Cancer Research top 10%
Papers in
- Oncology 6
- Colorectal Cancer Treatments and Studies 2
- Pancreatic and Hepatic Oncology Research 2
-
- Acute Myeloid Leukemia Research 3
- Co-authors
- Scott Kopetz (4 shared papers)Lanlan Shen (3 shared papers)Jean‐Pierre J. Issa (3 shared papers)Saira Ahmed (3 shared papers)Yi Guo (2 shared papers)Yutaka Kondo (2 shared papers)Horng‐Jyh Harn (2 shared papers)Tzyy‐Wen Chiou (2 shared papers)
- Journals
- Journal of Clinical Oncology (3 papers)Cancer (2 papers)Epigenetics (1 paper)Cancer Chemotherapy and Pharmacology (1 paper)Annals of Surgical Oncology (1 paper)
- Partner nations
- United StatesTaiwanChina
In The Last Decade
E. H. Lin
26 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 103
- Gastroenterology 184
- Cancer Research 332
- Hematology 247
- Oncology 561
- Hepatology 155
Countries citing papers authored by E. H. Lin
This map shows the geographic impact of E. H. Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. H. Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. H. Lin more than expected).
Fields of papers citing papers by E. H. Lin
This network shows the impact of papers produced by E. H. Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. H. Lin. The network helps show where E. H. Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside E. H. Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 461 | |
| 2 | 2009 | 296 | |
| 3 | 2019 | 217 | |
| 4 | 2009 | 191 | |
| 5 | 2008 | 141 | |
| 6 | 2013 | 105 | |
| 7 | 2006 | 103 | |
| 8 | 2010 | 97 | |
| 9 | 2014 | 76 | |
| 10 | 2010 | 69 | |
| 11 | 2008 | 56 | |
| 12 | Chemotherapy outcomes for the treatment of unresectable intrahepatic and hilar cholangiocarcinoma: a retrospective analysis. | 2011 | 55 |
| 13 | 2010 | 41 | |
| 14 | 2011 | 32 | |
| 15 | 2006 | 32 | |
| 16 | 2011 | 31 | |
| 17 | 2024 | 27 | |
| 18 | 1992 | 24 | |
| 19 | 2011 | 22 | |
| 20 | 2011 | 22 |
About E. H. Lin
E. H. Lin is a scholar working on Oncology, Hematology, Gastroenterology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 26 papers that have together received 2.1k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (3 papers), Lung Cancer Diagnosis and Treatment (2 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers), Epigenetics and DNA Methylation (2 papers), Colorectal Cancer Treatments and Studies (2 papers), Gastrointestinal Tumor Research and Treatment (2 papers), Pancreatic and Hepatic Oncology Research (2 papers) and Extracellular vesicles in disease (2 papers). The work is most often cited by research in Gastroenterology (184 citations), Cancer Research (332 citations), Hematology (247 citations), Oncology (561 citations) and Hepatology (155 citations). E. H. Lin has collaborated with scholars based in United States, Taiwan and China. Frequent co-authors include Scott Kopetz, Lanlan Shen, Jean‐Pierre J. Issa, Saira Ahmed, Yi Guo, Yutaka Kondo, Horng‐Jyh Harn, Tzyy‐Wen Chiou, Yu-Shuan Chen and Michael James Overman. Their work appears in journals such as Journal of Clinical Oncology, Cancer, Epigenetics, Cancer Chemotherapy and Pharmacology and Annals of Surgical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.